27/06/2024
CAD treatment decisions need to be made on a case-by-case basis, considering patients' specific needs, per a review study. https://buff.ly/45L10P4
Cold Agglutinin Disease News
- Home
- Cold Agglutinin Disease News
Cold Agglutinin Disease News is a digital platform providing daily updates on research, science and
(21)
24/06/2024
Columnist Mary Lott's days with cold agglutinin disease have helped her learn how to practice patience and anticipation. https://buff.ly/3RB24yX
20/06/2024
Obinutuzumab was an effective treatment for controlling primary cold agglutinin disease (CAD) in a woman in her 80s, per a case report. https://buff.ly/4c8zgWO
17/06/2024
Columnist Mary Lott's recent trip from Indonesia to the U.S. taught her some valuable lessons about how to travel with a chronic illness. https://buff.ly/4cnPB9R
13/06/2024
The CAD treatment Enjaymo (sutimlimab) needs to be about 80% cheaper to meet commonly-accepted thresholds for cost-effectiveness, a study says. https://buff.ly/4c0SUEg
10/06/2024
Both columnist Mary Lott and her motorcycle are growing old, requiring regular evaluations and treatments to keep them "running smoothly." https://buff.ly/3yXDxxN
06/06/2024
An accurate diagnosis of cold agglutinin disease requires a step-by-step process to identify the underlying cause, a report says. https://buff.ly/3X79lKE
03/06/2024
Living with CAD can result in many frustrating scenarios, says columnist Mary Lott. Here are her most common complaints. https://buff.ly/4bIR8ay
30/05/2024
Vermont Governor Phil Scott has signed into law a bill that improves access to the right medication at the right time among insured patients. https://buff.ly/3WWvhIm
27/05/2024
Columnist Mary Lott compares her treatment and care to the contents of a slingshot, a modest weapon that took down a mighty foe. https://buff.ly/3KDfBCB
23/05/2024
A third of adults with severe AIHA, conditions that include cold agglutinin disease, respond to IVIG therapy after seven days, a study found. https://buff.ly/3yuuyEb
20/05/2024
Cold agglutinin disease can be physically limiting, says columnist Mary Lott, but she's rising above thanks to other sources of strength. https://buff.ly/3K8UYxF
16/05/2024
A high-temperature setting helped prevent red blood cell clumping and cell destruction during plasmapheresis in a man with secondary CAD. https://buff.ly/4dFFDST
13/05/2024
It's a season of saying goodbyes in columnist Mary Lott's life, which makes her strategize to protect her health with groups or individuals. https://buff.ly/3yaOs6M
09/05/2024
A woman with both CAD and myelodysplastic syndrome responded well to treatment with the corticosteroid prednisolone followed by cyclosporine. https://buff.ly/3UzDWxF
06/05/2024
Changing careers to a job that is fulfilling, but not physically taxing, is a challenge, but columnist Mary Lott has some ideas. https://buff.ly/3UNB41h
02/05/2024
Daratumumab could offer a treatment option for refractory AIHA, including CAD, with more than half of patients in a study responding to it. https://buff.ly/4bka52V
29/04/2024
After helping her dog to confront a scary noise, columnist Mary Lott considers the value of facing fears head-on in life with CAD. https://buff.ly/4dfpXFJ
22/04/2024
To prepare for an annual doctor's appointment, columnist Mary Lott has identified six key issues to discuss, along with several questions. https://buff.ly/3xWXu7a
18/04/2024
A report of cold agglutinin disease secondary to a blood cancer in an elderly woman highlights the potential flaws of a direct Coombs test. https://buff.ly/49FXg1K
15/04/2024
Columnist Mary Lott offers appreciation to her husband, Mike, who often helps out around the house when Mary is fatigued from CAD. https://buff.ly/3VUTKNL
11/04/2024
Children and teens with AIHA responded well to first-line treatment as recommended for adults, a retrospective, single-center study found. https://buff.ly/3PY2Fdi
08/04/2024
Columnist Mary Lott loves using her solar dryer (aka a clothesline) to air out laundry. But she must plan the chore around her need for rest. https://buff.ly/43NeKI5
04/04/2024
COVID-19 worsened the symptoms of cold agglutinin disease in a 71-year-old man in whom the autoimmune disease had been stable. https://buff.ly/49mvsz9
01/04/2024
As heavy rains fall on her home in Indonesia, columnist Mary Lott considers the extra challenges she could face with cold agglutinin disease. https://buff.ly/4cH7Jwo
20/11/2023
Pre-treatments with rituximab and plasma exchange limited complications of
cold agglutinin disease (CAD) during surgery, a case report shows. Read more: https://bit.ly/3SIf876
18/11/2023
Here is this week's most-read article featured on our website! Are you caught up?
A bipartisan group is proposing new legislation that aims to make it easier for people with rare disorders to access off-label treatments.
https://buff.ly/49xDK8L
15/11/2023
COVID-19 led to a severe, mixed form of autoimmune hemolytic anemia (AIHA) in a previously healthy 2-year-old girl in the U.S.
https://buff.ly/3QWJX6J
15/11/2023
Interpreting lab results without waiting for the doctor when managing CAD can cause unnecessary anxiety, writes columnist Mary Lott.
https://buff.ly/47d9iPJ
13/11/2023
Cold agglutinin disease (CAD) diagnosis was among the topics in a recent webinar on the disorder. Columnist Mary Lott offers her takeaways. https://buff.ly/46s5RUd
Address
Website
Alerts
Be the first to know and let us send you an email when Cold Agglutinin Disease News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Shortcuts
- Address
- Alerts
- Claim ownership or report listing
-
Want your business to be the top-listed Media Company?
Share
